Neogen (NASDAQ:NEOG) Shares Gap Up – Here’s Why

Neogen Corporation (NASDAQ:NEOG) gapped up prior to trading on Wednesday . The stock had previously closed at $11.64, but opened at $12.18. Neogen shares last traded at $11.9940, with a volume of 161,083 shares trading hands.

Trending Headlines about Neogen

Here are the key news stories impacting Neogen this week:

• Positive Sentiment: Zacks Research raised its fiscal 2028 EPS forecast for Neogen to $0.29 from $0.28. The firm also increased estimates for several periods, including Q2 2027 to $0.08 from $0.07, Q3 2027 to $0.06 from $0.05, and Q4 2027 to $0.07 from $0.06. These revisions suggest improving expectations for the company’s future profitability. MarketBeat Neogen analyst estimates
• Positive Sentiment: Zacks also lifted its Q3 2028 EPS estimate to $0.07 from $0.06 and its Q4 2028 estimate to $0.09 from $0.08. The current-year consensus remains $0.25 per share, while the higher fiscal 2028 outlook provides a longer-term earnings-growth narrative for investors. MarketBeat Neogen earnings estimates
• Neutral Sentiment: Reported short interest was listed at zero shares, producing a zero-day short-interest ratio. Because the figures appear inconsistent and provide no meaningful short-covering signal, the data is unlikely to be a reliable driver of the stock. MarketBeat Neogen short interest
• Negative Sentiment: An analyst price-target report cited a target of $11.67, which is below the stock’s recent trading level and could signal limited near-term upside. Analysts set Neogen price target
• Negative Sentiment: Zacks lowered its Q1 2028 EPS forecast to $0.05 from $0.06, partially offsetting the broader series of upward revisions. Neogen also continues to trade at a demanding valuation relative to current earnings, making execution and sustained profit growth important.

Wall Street Analyst Weigh In

Several equities analysts have weighed in on the company. Weiss Ratings upgraded Neogen from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Friday, August 7th. Wall Street Zen upgraded shares of Neogen from a “hold” rating to a “buy” rating in a report on Saturday, May 9th. Finally, Piper Sandler raised shares of Neogen from a “neutral” rating to an “overweight” rating and set a $14.00 price target on the stock in a research report on Wednesday. Three research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, Neogen currently has a consensus rating of “Hold” and an average price target of $12.00.

Neogen Stock Up 1.7%

The stock’s 50-day moving average price is $10.31 and its two-hundred day moving average price is $9.84. The stock has a market capitalization of $2.58 billion, a P/E ratio of -393.50, a P/E/G ratio of 4.58 and a beta of 1.77. The company has a current ratio of 3.82, a quick ratio of 2.91 and a debt-to-equity ratio of 0.38.

Neogen (NASDAQ:NEOG) last posted its quarterly earnings results on Thursday, July 30th. The company reported $0.09 EPS for the quarter, topping analysts’ consensus estimates of $0.06 by $0.03. Neogen had a negative net margin of 0.91% and a positive return on equity of 2.78%. The company had revenue of $225.30 million for the quarter, compared to analysts’ expectations of $212.35 million. During the same quarter in the previous year, the firm posted ($2.82) EPS. Neogen’s revenue was down .1% on a year-over-year basis. As a group, research analysts expect that Neogen Corporation will post 0.25 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Neogen

Large investors have recently added to or reduced their stakes in the company. Nykredit A S purchased a new stake in Neogen during the second quarter valued at about $28,000. Public Employees Retirement System of Ohio purchased a new position in shares of Neogen in the second quarter worth about $34,000. UMB Bank n.a. lifted its stake in shares of Neogen by 238.2% during the 4th quarter. UMB Bank n.a. now owns 6,422 shares of the company’s stock valued at $45,000 after buying an additional 4,523 shares in the last quarter. Hantz Financial Services Inc. lifted its stake in shares of Neogen by 816.9% during the 4th quarter. Hantz Financial Services Inc. now owns 7,592 shares of the company’s stock valued at $53,000 after buying an additional 6,764 shares in the last quarter. Finally, Cresset Asset Management LLC bought a new position in Neogen in the 2nd quarter worth approximately $53,000. Hedge funds and other institutional investors own 96.73% of the company’s stock.

Neogen Company Profile

Neogen Corporation is a global provider of food and animal safety products, offering a broad portfolio of diagnostic and testing solutions. Headquartered in Lansing, Michigan, the company develops and manufactures tests designed to detect foodborne pathogens, allergens and toxins in food, beverage and environmental samples. Since its founding in 1982, Neogen has focused on delivering rapid, accurate and user‐friendly assays to food processors, grain handlers and quality laboratories around the world.

In the food safety arena, Neogen’s product lineup includes immunoassay kits, molecular diagnostics and enrichment media for pathogens such as Salmonella, Listeria and E.